GRAIL, Inc. (GRAL) stock
GRALNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$104.84+2.74 (+2.68%)
Close on Nov 19, 2026Market cap $4.68BP/E –Yield –
Grail net income
Net income is the profit left for shareholders after every expense, interest and tax.
Grail's net income for the twelve months ending Jun 30, 2026 was -$391.59M. For fiscal 2025 it was -$408.35M.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$408.35M | – |
| FY2024 | Dec 31, 2024 | -$2.03B | – |
| FY2023 | Dec 31, 2023 | -$1.47B | – |
| FY2022 | Jan 1, 2023 | -$5.40B | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$110.25M | – |
| Q1 FY2026 | Mar 31, 2026 | -$93.19M | – |
| Q4 FY2025 | Dec 31, 2025 | -$99.18M | – |
| Q3 FY2025 | Sep 30, 2025 | -$88.98M | – |
| Q2 FY2025 | Jun 30, 2025 | -$113.99M | – |
| Q1 FY2025 | Mar 31, 2025 | -$106.21M | – |
| Q4 FY2024 | Dec 31, 2024 | -$97.07M | – |
| Q3 FY2024 | Sep 30, 2024 | -$125.69M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.59B | – |
| Q1 FY2024 | Mar 31, 2024 | -$218.91M | – |
| Q4 FY2023 | Dec 31, 2023 | -$187.53M | – |
| Q3 FY2023 | Oct 1, 2023 | -$891.45M | – |
| Q2 FY2023 | Jun 30, 2023 | -$193.05M | – |
| Q1 FY2023 | Apr 2, 2023 | -$193.67M | – |
See a number that looks wrong?